Literature DB >> 29344699

Feasibility study of MR-guided transgluteal targeted in-bore biopsy for suspicious lesions of the prostate at 3 Tesla using a freehand approach.

Frank Fischbach1, Lukas Wien2, Sascha Krueger3, Bernhard Schnackenburg3, Daniel Baumunk4, Björn Friebe2, Martin Schostak4, Jens Ricke2, Katharina Fischbach2.   

Abstract

OBJECTIVE: The aim of our study was (1) to establish an in-bore targeted biopsy of suspicious prostate lesions, avoiding bowel penetration using a transgluteal approach and (2) to assess operator setup, patient comfort and safety aspects in the clinical setting for freehand real-time MR-guidance established for percutaneous procedures in an open MR-scanner.
MATERIAL AND METHODS: 30 patients with suspect prostate lesions were biopsied in a cylindrical 3T-MRI system using a transgluteal approach in freehand technique. One to three biopsies were sampled using continuous dynamic imaging. Size, location and visibility of the lesion, intervention time, needle artefact size, interventional complications and histopathological diagnosis were recorded.
RESULTS: All biopsies were technically successful. Nineteen patients showed evidence of prostate carcinoma. Cancer detection rate was 50 % in patients with previously negative TRUS-biopsy. The average intervention time was 26 min including a learning curve as the time was 13 min by the end of the study. No antibiotic prophylaxis was performed as none of the patients showed signs of infection.
CONCLUSIONS: MR-guided targeted freehand biopsies of prostate lesions using a transgluteal approach are both technically feasible and time efficient in a standard closed-bore 3T-MR scanner as well as safe for the individual patient. KEY POINTS: • Open-bore freehand interventional principles were adapted to closed-bore systems. • Prostate MR-guided freehand biopsies were feasible in a clinical setting. • A transgluteal approach provides a short and simplified work flow. • An inoculation of the prostate with bowel flora is avoided. • The intervention time is comparable to the stereotactic approach.

Entities:  

Keywords:  Fluoroscopic guidance; Interventional MR; Prostate biopsy; Prostate cancer; Targeted biopsy

Mesh:

Year:  2018        PMID: 29344699     DOI: 10.1007/s00330-017-5187-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  23 in total

1.  MR imaging guided percutaneous nephrostomy using a 1.0 Tesla open MR scanner.

Authors:  Frank Fischbach; Markus Porsch; Felix Krenzien; Maciej Pech; Oliver Dudeck; Jürgen Bunke; Uwe-Bernd Liehr; Jens Ricke
Journal:  Cardiovasc Intervent Radiol       Date:  2010-12-16       Impact factor: 2.740

2.  Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.

Authors:  Felix K-H Chun; Thomas Steuber; Andreas Erbersdobler; Eike Currlin; Jochen Walz; Thorsten Schlomm; Alexander Haese; Hans Heinzer; Michael McCormack; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2005-12-22       Impact factor: 20.096

3.  Prostatic biopsy after proctocolectomy: a transgluteal, CT-guided approach.

Authors:  N Papanicolaou; P J Eisenberg; S G Silverman; M M McNicholas; A F Althausen
Journal:  AJR Am J Roentgenol       Date:  1996-06       Impact factor: 3.959

4.  MR-guided freehand biopsy of breast lesions in a 1.0-T open MR imager with a near-real-time interactive platform: preliminary experience.

Authors:  Frank Fischbach; Holm Eggemann; Juergen Bunke; Uta Wonneberger; Jens Ricke; Katharina Strach
Journal:  Radiology       Date:  2012-08-24       Impact factor: 11.105

5.  Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference.

Authors:  H A Vargas; A M Hötker; D A Goldman; C S Moskowitz; T Gondo; K Matsumoto; B Ehdaie; S Woo; S W Fine; V E Reuter; E Sala; H Hricak
Journal:  Eur Radiol       Date:  2015-09-22       Impact factor: 5.315

6.  Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.

Authors:  Christian Arsov; Robert Rabenalt; Dirk Blondin; Michael Quentin; Andreas Hiester; Erhard Godehardt; Helmut E Gabbert; Nikolaus Becker; Gerald Antoch; Peter Albers; Lars Schimmöller
Journal:  Eur Urol       Date:  2015-06-23       Impact factor: 20.096

7.  Biopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer?

Authors:  E T Fernandes; C P Sundaram; R Long; M Soltani; C J Ercole
Journal:  Br J Urol       Date:  1997-04

Review 8.  Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.

Authors:  Ivo G Schoots; Monique J Roobol; Daan Nieboer; Chris H Bangma; Ewout W Steyerberg; M G Myriam Hunink
Journal:  Eur Urol       Date:  2014-12-03       Impact factor: 20.096

9.  Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence.

Authors:  Gabriel P Haas; Nicolas Barry Delongchamps; Richard F Jones; Vishal Chandan; Angel M Serio; Andrew J Vickers; Mary Jumbelic; Gregory Threatte; Rus Korets; Hans Lilja; Gustavo de la Roza
Journal:  J Natl Cancer Inst       Date:  2007-09-25       Impact factor: 13.506

10.  Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.

Authors:  Thomas Hambrock; Jurgen J Fütterer; Henkjan J Huisman; Christina Hulsbergen-vandeKaa; Jean-Paul van Basten; Inge van Oort; J Alfred Witjes; Jelle O Barentsz
Journal:  Invest Radiol       Date:  2008-10       Impact factor: 6.016

View more
  2 in total

1.  Comparison of analgesic techniques in MRI-guided in-bore prostate biopsy.

Authors:  M Quentin; C Arsov; T Ullrich; B Valentin; A Hiester; D Blondin; P Albers; G Antoch; L Schimmöller
Journal:  Eur Radiol       Date:  2019-06-27       Impact factor: 5.315

2.  MRI targeted single fraction HDR Brachytherapy for localized Prostate Carcinoma: a feasibility study of focal radiation therapy (ProFocAL).

Authors:  Frank Fischbach; Peter Hass; Daniel Schindele; Philipp Genseke; Lisa Geisendorf; Christian Stehning; Martin Schostak; Thomas Brunner; Maciej Pech; Katharina Fischbach
Journal:  Eur Radiol       Date:  2019-12-11       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.